• Home
  • Journal
  • Mergers And Acquisitions
  • Connected Drug Delivery Devices Market to reach USD 4,062.7 Million by 2026; Increasing Prevalence of Diabetes & Asthma to Boost Growth: Fortune Business

Connected Drug Delivery Devices Market to reach USD 4,062.7 Million by 2026; Increasing Prevalence of Diabetes & Asthma to Boost Growth: Fortune Business

Pune, Dec. 02, 2019 (GLOBE NEWSWIRE) — The global Connected Drug Delivery Devices Market size is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026.” As per the report, a rising incidence of diabetes, COPD, and asthma are anticipated to boost the Connected Drug Delivery Devices Market growth in the coming years.
To gain more insights into the market with detailed table of content and figures, click here:

Highlights of the Report
Elaborate information regarding the Connected Drug Delivery Devices Market trends, growth drivers, obstacles, opportunities, and challenges.Competitive landscape, namely, mergers & acquisitions, new product launches, agreements, etc.Regional analysis consisting of North America, Europe, Asia pacific, and Rest of the World.Rising Emphasis on Preventive Care of Chronic Diseases to Propel GrowthA rising incidence of chronic diseases across the world is creating more opportunities for the Connected Drug Delivery Devices Market growth. In 2016, the Global Burden of Disease Study mentioned that the prevalence of COPD went up by approximately 14.7 percent between the period of 1990 to 2015. Besides, connected drug delivery devices possess various novel benefits. So, people are rapidly inclining towards them by replacing the manual devices.Moreover, an increasing focus on preventive care of chronic disorders is likely to contribute to the market growth in the coming years. The Lancet Respiratory Medicine, for instance, had published a study in 2015 that highlighted that in New Zealand, the adoption of smart inhalers grew up to 84.0 percent amongst asthmatic children from 2014 to 2015.
Request a Sample Copy: https://www.fortunebusinessinsights.com/enquiry/sample/connected-drug-delivery-devices-market-100380

Bluetooth Segment to Dominate: Need to Connect Smartphones with Drug Delivery Devices Will Surge Demand
In terms of technology, the market is grouped into near field communication (NFC), Bluetooth, and others. The Bluetooth segment is expected to lead the market. It is occurring because of the increasing utilization of this technology for connecting drug delivery devices with smartphones. Apart from that, ease-of-use, as well as high compatibility of this technology with other devices, would drive the growth of this segment. NFC devices, on the other hand, provide superior data transmission and extended battery life. These properties would increase the adoption of these devices in the near future.Key Market PlayersFortune Business Insights profiles some of the renowned companies operating in the Connected Drug Delivery Devices Market. They are as follows:BDProteus Digital HealthCohero Health, Inc.F. Hoffmann-La Roche Ltd.AdheriumWest Pharmaceutical ServicesYpsomed HoldingPropeller Health (A ResMed Company)
Increasing Demand for Digital Medical Devices to Favor Growth in Europe
North America had generated USD 253.0 million Connected Drug Delivery Devices Market revenue in 2018. The region is anticipated to lead the market throughout the forthcoming years. Strategic collaborations, existence of major players, increasing healthcare expenditure, and well-established infrastructure are some of the most significant drivers of the market in this region. Europe is experiencing a rising demand for digital medical devices as well as a higher adoption of connected drug delivery devices on account of an urgent requirement to improve the patient experience.Asia Pacific is showcasing a rise in the number of awareness programs regarding the cost benefits of connected drug delivery devices. It is also exhibiting an increasing adoption of innovative medical technology. These factors are set to create high growth opportunities.FindAir Launches its Smart Inhaler Device Called FindAir ONE in EuropeJanuary 2019: FindAir, a developer of digital systems for asthma and COPD control, based in Poland, announced the launch of FindAir ONE in Europe. It is a commercial smart inhaler device that can be connected to an accompanying web or mobile app wirelessly for doctors and patients alike. It is to be attached to the COPD or asthma rescue medication in the form of a pMDI inhaler. It gathers information about the usage of each drug as well as the circumstances of that use.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/connected-drug-delivery-devices-market-100380

Table of Content:
IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsTechnological advancements in Connected Drug Delivery Devices MarketRecent Industry Developments- Partnerships, Mergers, And AcquisitionsNew Product Launches by Key PlayersRegulatory ScenariosTrends of Usage of Connected Drug Delivery DevicesGlobal Connected Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeInjectable DevicesInhalation Devices and OthersMarket Analysis, Insights and Forecast – By TechnologyBluetoothNFC (Near Field Communication)OthersMarket Analysis, Insights and Forecast – By End UserHomecare SettingsHospitalsMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia pacificRest of the WorldTOC Continued….!

Order Single or Multi-User License Copy: https://www.fortunebusinessinsights.com/checkout-page/100380

(Have a Look at Trending Reports in Healthcare

Have a Look at Related Reports:
Medical Devices Market Size, Share and Industry Analysis By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care, Ophthalmic Devices, Dental & Nephrology), End User (Hospitals & Ambulatory Surgical Centers and Clinics) and Regional Forecast, 2019 – 2025Telemedicine Market Size, Share & Industry Analysis By Type (Products, Services), By Application (Teleradiology, Telepathology, Teledermatology, Telepsychiatry, Telecardiology, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Others), By End User (Healthcare Facilities, Homecare), and Regional Forecast 2019-2026Telehealth Market Size, Share and Industry Analysis by Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2019 – 2026Knee Replacement Market Size, Share & Industry Analysis, By Procedure (Total Knee Arthroplasty, Partial Knee Arthroplasty, and Revision Arthroplasty) By Implant Type (Fixed Bearing, Mobile Bearing, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026Immune Thrombocytopenia (ITP) Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026Spinal Devices Market Size, Share & Industry Analysis, By Product Type (Fusion Devices (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), Non-Fusion Devices (Vertebral Compression Fracture Devices, Artificial Discs, Dynamic Stabilization Devices, and Others), and Stimulation Devices) By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory SurgeSpinal Fusion Devices Market Size, Share & Industry Analysis, By Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026About Us:Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.